- Report
- June 2026
- 328 Pages
Global
From €4441EUR$4,950USD£3,800GBP
- Report
- April 2026
- 148 Pages
Global
From €2691EUR$2,999USD£2,302GBP
€3588EUR$3,999USD£3,070GBP
- Report
- April 2026
- 150 Pages
Global
From €5338EUR$5,950USD£4,568GBP
- Report
- November 2025
- 140 Pages
Global
From €5338EUR$5,950USD£4,568GBP
- Report
- October 2025
- 120 Pages
Global
From €5338EUR$5,950USD£4,568GBP
- Report
- August 2026
- 382 Pages
Global
From €5248EUR$5,850USD£4,491GBP
- Report
- October 2025
- 183 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,024GBP
- Report
- January 2026
- 187 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,024GBP
- Report
- January 2026
- 181 Pages
Global
From €4037EUR$4,500USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- October 2025
- 198 Pages
Global
From €4037EUR$4,500USD£3,454GBP
- Report
- May 2026
- 153 Pages
Global
From €3544EUR$3,950USD£3,032GBP
- Report
- May 2026
- 154 Pages
Global
From €3544EUR$3,950USD£3,032GBP
- Report
- May 2026
- 157 Pages
Global
From €3544EUR$3,950USD£3,032GBP
- Report
- May 2026
- 150 Pages
Global
From €3544EUR$3,950USD£3,032GBP

Cervical cancer is a type of cancer that affects the cells of the cervix, the lower part of the uterus that connects to the vagina. It is the fourth most common cancer in women worldwide, and is caused by the human papillomavirus (HPV). Treatment for cervical cancer typically involves surgery, radiation therapy, chemotherapy, and targeted therapy.
The cervical cancer market is a subset of the larger oncology market, which is composed of drugs, diagnostics, and services used to treat cancer. The cervical cancer market is expected to grow due to the increasing prevalence of HPV, the development of new treatments, and the increasing availability of healthcare services.
Some companies in the cervical cancer market include Merck, Bristol-Myers Squibb, AstraZeneca, Roche, and Novartis. Show Less Read more